PUBLISHER: Blueweave Consulting | PRODUCT CODE: 1301776
PUBLISHER: Blueweave Consulting | PRODUCT CODE: 1301776
United Kingdom in vitro fertilization (IVF) market is flourishing because of an increasing number of fertility clinics, declining fertility rate, and growing rate of obesity and increased consumption of alcohol.
BlueWeave Consulting, a leading strategic consulting and market research firm, in its recent study, estimated the United Kingdom in vitro fertilization (IVF) market size at USD 620.03 million in 2022. During the forecast period between 2023 and 2029, BlueWeave expects the United Kingdom in vitro fertilization (IVF) market size to grow at a significant CAGR of 7.77% reaching a value of USD 1,038.68 million by 2029. Major growth drivers for the United Kingdom in vitro fertilization market include increasing awareness regarding assisted reproductive technology, growing favorable regulatory measures supporting IVF treatments, and the introduction of commercialized three-parent IVF procedures. The country has numerous fertility clinics and centers that offer a range of ART treatments, including IVF, intracytoplasmic sperm injection (ICSI), and preimplantation genetic testing (PGT). The increasing prevalence of infertility and a rise in the average age of parenthood have fueled the demand for IVF services in the United Kingdom. Changing social attitudes, advancements in IVF technologies, and improving success rates have also played a crucial role in the market's expansion. The United Kingdom has a supportive legal framework regarding ART and fertility treatment, ensuring the rights and safety of patients and regulating the practices of fertility clinics. The National Health Service (NHS) offers IVF treatment to eligible couples, also contributing to the accessibility and adoption of IVF services. The advancements in reproductive technologies, such as the utilization of time-lapse imaging, genetic screening, and embryo freezing, have improved success rates and expanded treatment options, attracting both domestic and international patients to seek IVF services in the United Kingdom. The market is further influenced by factors such as increasing public awareness about infertility treatments, higher disposable income levels, and the willingness of individuals to invest in fertility treatments to fulfill their desire for parenthood. However, high cost associated with IVF procedures and restrictive regulations and ethical concerns are anticipated to restrain the overall market growth during the period in analysis.
In vitro fertilization (IVF) is a widely practiced laboratory-based treatment for infertility. This assisted reproductive technology involves the extraction of one or more eggs from the ovaries, which are then fertilized by sperm in a controlled environment outside the body. It is a prominent fertility treatment within the clinical field. The IVF process encompasses several stages, including ovarian stimulation, egg retrieval, fertilization through insemination, embryo culture, and ultimately, the transfer of the developed embryo into the uterus. The duration of the treatment spans several months. In cases where natural methods have been unsuccessful, IVF offers an alternative approach to achieving conception.
COVID-19 pandemic adversely affected United Kingdom in vitro fertilization (IVF) market. The restrictions and disruptions caused by the crisis have led to the postponement and cancellation of IVF treatments, creating delays for individuals and couples seeking fertility assistance. Financial constraints resulting from job losses and economic downturn have also affected the accessibility of IVF services. Psychological factors such as stress and concerns about the health risks associated with COVID-19 have influenced individuals' decisions regarding pursuing or delaying IVF treatments. However, with the implementation of safety protocols and the progress of vaccination efforts, it is anticipated that the IVF market will gradually recover as the demand for fertility treatments persists.
Based on cycle type, the United Kingdom in vitro fertilization (IVF) market is divided into Fresh Donor, Frozen Donor, Fresh Non-donor, and Frozen Non-donor segments. The frozen non-donor segment held the highest share in the IVF market in 2022. This segment's dominance can be attributed to several factors, including its cost-effectiveness compared to fresh non-donor procedures and its minimally invasive nature. The fresh non-donor segment held the second-highest revenue share in 2021. The implementation of the vitrification process, endorsed by the International Federation of Fertility Societies, has enabled sperm donation even for HIV-positive patients by directly isolating sperm from plasma. Intracytoplasmic Sperm Injection (ICSI) offers hope to individuals with azoospermia in achieving conception. As women age, the success rate of IVF declines significantly, particularly in those over 40 years old. Consequently, donor eggs are commonly employed in this demographic. The shared donor egg program allows a single donor to contribute eggs to multiple recipients, ensuring fertility rates are not compromised. This program is not only cost-effective but also beneficial for the recipients.
Major players operating in the United Kingdom in vitro fertilization (IVF) market include: Bourn Hall Clinic, CARE Fertility Group, HCA International Limited, TFP Fertility Group, CREATE Fertility, The Centre for Reproductive & Genetic Health, London Women's Clinic, Manchester Fertility, Chelsea and Westminster Hospital, and The Bridge Centre. To further enhance their market share, these companies employ various strategies, including mergers and acquisitions, partnerships, joint ventures, license agreements, and new product launches.
The in-depth analysis of the report provides information about growth potential, upcoming trends, and statistics of United Kingdom In Vitro Fertilization (IVF) Market. It also highlights the factors driving forecasts of total market size. The report promises to provide recent technology trends in United Kingdom In Vitro Fertilization (IVF) Market and industry insights to help decision-makers make sound strategic decisions. Furthermore, the report also analyzes the growth drivers, challenges, and competitive dynamics of the market.
*Financial information of case of non-listed companies can be provided as per availability.
**The segmentation and the companies are subject to modifications based on in-depth secondary research for the final deliverable.